- Home
- ASND vs OC Comparison
ASND vs OC Comparison
Compare ASND & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- OC
- Stock Information
- Founded
- ASND 2006
- OC 1938
- Country
- ASND Denmark
- OC United States
- Employees
- ASND N/A
- OC N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- OC Industrial Machinery/Components
- Sector
- ASND Health Care
- OC Industrials
- Exchange
- ASND Nasdaq
- OC Nasdaq
- Market Cap
- ASND 9.8B
- OC 11.3B
- IPO Year
- ASND 2015
- OC N/A
- Fundamental
- Price
- ASND $176.90
- OC $131.10
- Analyst Decision
- ASND Strong Buy
- OC Buy
- Analyst Count
- ASND 16
- OC 11
- Target Price
- ASND $218.19
- OC $186.90
- AVG Volume (30 Days)
- ASND 411.5K
- OC 941.2K
- Earning Date
- ASND 05-01-2025
- OC 08-05-2025
- Dividend Yield
- ASND N/A
- OC 2.10%
- EPS Growth
- ASND N/A
- OC N/A
- EPS
- ASND N/A
- OC 2.92
- Revenue
- ASND $398,509,511.00
- OC $11,488,000,000.00
- Revenue This Year
- ASND $75.05
- OC N/A
- Revenue Next Year
- ASND $78.14
- OC $2.01
- P/E Ratio
- ASND N/A
- OC $44.95
- Revenue Growth
- ASND 12.06
- OC 22.70
- 52 Week Low
- ASND $111.09
- OC $123.41
- 52 Week High
- ASND $183.00
- OC $214.53
- Technical
- Relative Strength Index (RSI)
- ASND 60.02
- OC 41.87
- Support Level
- ASND $169.65
- OC $130.46
- Resistance Level
- ASND $178.62
- OC $143.27
- Average True Range (ATR)
- ASND 6.77
- OC 3.51
- MACD
- ASND 0.03
- OC -0.37
- Stochastic Oscillator
- ASND 82.61
- OC 12.06
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About OC Owens Corning Inc New
Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.